Bengt, I., Eriksson, Bergqvist, D., Ka¨leboet, P. et al. Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial. Lancet, 360:1441, 2002.
Colwell, C. W., Collis, D. K., Paulson, R. et al. Comparison of enoxaparin and warfarin for the prevention of venous thrombo-embolic disease after total hip arthroplasty. Evaluation and human hospitalization three months after discharge. J. Bone Joint Surg.,
92:81–8, 1999. Goldhaber, S. Z., Turpie, A. G. G. et al. Prevention of venous throm-boembolism among hospitalized medical patients. Circulation,
111:e1–e3, 2005. Hull R. D., Pineo, G. F., Francis, C. et al. Low-molecular-weight heparin
prophylaxis using dalteparin in close proximity to surgery vs. warfarin
in hip arthroplasty patients: A double-blind, randomized comparison.
North American Fragmin Trial Investigators. Arch. Intern. Med.,
160:2199–2207, 2000. Kelly, J., and Hunt, B. J. Role of D-dimers in diagnosis of venous
thromboembolism. Lancet, 359:456–57, 2002. Khan, M. Gabriel. On Call Cardiology, 2nd edition, W. B. Saunders,
Philadelphia, 2001, pp. 357–71. Kucher, N., Koo, S., Quiroz, R. et al. Electronic alerts to prevent venous

Страницы: 1 | 2